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Objective: Pharmacoresistance continues to be a major challenge in Temporal Lobe Epilepsies (TLE). A
key to overcome pharmacoresistance is to identify subgroups among the TLE and disclose their speciﬁc
molecular pathways. This will facilitate a tailored pharmacological treatment and improve outcome.
There is growing evidence in favor of the theory that TLE with childhood febrile seizures (TLE-FS) may
represent one distinctive subgroup among the TLE.
Material and methods: We compared clinical features from 102 TLE-FS patients with 105 TLE patients
without FS. We also conducted a logistic regression analysis to adjust for possible confounders caused by
overrepresentation of patients with Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-
HS) in the TLE-FS group.
Results: MTLE-HS was overrepresented in patients with TLE-FS (p = 0.043). Age at epilepsy onset was
lower in patients with TLE-FS (p < 0.001). TLE-FS patients had a higher frequency of ﬁrst grade family
members with FS (p = 0.003, adjusted for MTLE-HS: p = 0.002). They were more frequently plagued with
simple partial seizures (p = 0.015, adjusted: p = 0.038), and especially with vertiginous symptoms
(p = 0.004 adjusted: p = 0.006). They also had the higher frequency of autonomic symptoms (p = 0.003;
adjusted: p = 0.012), and more generalized tonic–clonic seizures (0.034; adjusted p = 0.038).
Conclusion: We identiﬁed TLE-FS as a phenotype that can be delineated from other TLE. None of the
characteristics are speciﬁc, but we disclosed a set of features also when adjusted for MTLE-HS.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Temporal Lobe Epilepsies (TLE) are fascinating conditions as
they raise fundamental questions about brain development,
neuroplasticity, molecular- and genetic pathways of epileptogen-
esis and mechanisms of pharmacoresistance. The term TLE simply
refers to the location where seizures arise and does not allude to a
common pathogenesis. Yet, TLE consist of several entities with
different etiological backgrounds.
Despite recent medical advances patients with TLE continue to
frequently display pharmacoresistance and often require temporal
lobectomy to achieve seizure control.1 Thus there is an urgent need
to develop new therapy strategies for TLE. One of the most
important future tasks to overcome medical intractability is to* Corresponding author. Tel.: +47 230 70472; fax: +47 230 70490.
E-mail addresses: kjell.heuser@oslo-universitetssykehus.no,
dr.heuser@gmail.com (K. Heuser).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.11.015identify distinguishable entities among the TLE and tailor
pharmacological treatment to the respective. Delineation of
subgroups is however challenging as they exhibit similar
phenotypes and are determined by complex polygenetic inheri-
tance and largely unidentiﬁed environmental factors.
There is a growing list of indications in literature that TLE
patients who suffered from febrile seizures in early childhood
(TLE-FS) constitute a unique entity distinct from afebrile TLE.2–4 In
fact, studies on several large pedigrees suggest that TLE and FSmay
have a common genetic basis, whether hippocampal sclerosis is
present or not.5–7 These studies are reinforced by data from our
recent association study that indicates genetic variants in TLE-FS.8
In this respect the question arises whether TLE-FS display a
phenotype that can be distinguished from other TLE. To address
this issue, we here perform a comparative analysis of two TLE
patient cohorts – one cohort with FS and one without FS – in order
to identify phenotypic characteristics associated with TLE-FS. This
is the ﬁrst study to systematically investigate clinical character-
istics of patients with TLE-FS.vier Ltd. All rights reserved.
Table 1
Patient characteristics of TLE-FS patients compared with TLE patients without FS.
TLE-FS TLE without FS
Patients n 102 105
Sex Female 50 65
Male 52 40
Median age (years) when entering the
study
39 (18–70) 41 (18–66)
Median duration (years) of epilepsy
when entering the study
23 (1–55) 22 (1–55)
Patients with Hippocampal Sclerosis
(MTLE-HS)
33 21
Surgery Vagal nerve stimulator 7 3
Temporal lobectomy 30 22
First grade family members with FS 24 9
Seizure-free period of at least 5 years
within the last 10 years before enter-
ing the study
28 23
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2.1. Patient collection
Patient data were collected between 2000 and 2004 in a
cooperative project (GenEpA), involving only tertiary Norwegian
centers with high competence in the ﬁeld of epileptology. 207
patients with TLE (according to the ILAE criteria, see www.ilae.org)
were included. Inclusion criteria for all individuals were: age > 18
years; Caucasian race, with at least 3 of 4 grandparents of
Scandinavian origin. Patients ﬁlled out standardized evaluation
forms togetherwith the treating physician or epilepsy nurse. These
forms were controlled by the treating epileptologist and lacking
information was added based on the medical records. MRI
(typically 1 or 1.5 T, with sagittal and axial T1, axial and coronal
T2 and FLAIR) was performed in all patients in order to identify
abnormalities such as hippocampal sclerosis, temporal lobe
atrophy and mass lesions. TLE patients with FS were compared
with those patients without FS. We analyzed patient data as age,
sex, age at epilepsy onset, incidence of FS in ﬁrst grade family
members, incidence of hippocampal sclerosis or other abnormali-
ties in MRI, and clinical characteristics as seizure semiology and
other ictal and interictal symptoms.
2.2. Data analysis
Categorical variables were described with proportions, contin-
uous with median and range. Associations between variables were
studied using Chi-square tests or Fisher’s exact tests (when
number of observations was too small for one or both variables).
Crude association between the two patient subgroups and age of
epilepsy onset were assessed using Cochran–Armitage test for
trend.9 To correct for possible confounding caused by overrepre-
sentation of MTLE-HS in TLE-FS, multiple logistic regression
models were adjusted for MTLE-HS and the results expressed as
odds ratios (OR) with 95% conﬁdence intervals (CI). p-
Values < 0.05were considered statistically signiﬁcant. All analyses
were computed using SPSS, ver.16.
3. Results
3.1. Patient characteristics
Age at epilepsy onset was lower in patients with TLE-FS
(p < 0.001) (Fig. 1). Patients with MTLE-HS were overrepresented
in the TLE-FS group (p = 0.043). TLE-FS patients had more than
three times higher frequency of ﬁrst grade family members with
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Fig. 1. Age at epilepsy onset in TLE-FS patients compared with TLE patients without
FS. p-Value < 0.001.childhood febrile seizures (p = 0.003, adjusted for MTLE-HS: OR
3.85; 95% CI 1.66–8.9). Further patient characteristics are
summarized in Table 1.
3.2. Ictal and interictal features
TLE-FS patients were more frequently plagued with simple
partial seizures (p = 0.015, adjusted OR 1.87; 95% CI 1.04–3.37),
and especially with vertiginous symptoms (p = 0.004 adjusted OR
6.04; 95% CI 1.66–21.92) and psychic symptoms as de´ja` vu, jamais
vu and ictal fear (p = 0.047). They also had the higher frequency of
ictal autonomic symptoms (p = 0.003; adjusted OR 2.2, 95% CI 1.2–
4.1), and displayed more often generalized tonic–clonic seizures
(0.034; adjusted OR 2.5, 95% CI 1.1–6.4). Ictal features are
summarized in Table 2. Interictally, TLE-FS patients showed
borderline more often abnormal psychiatric or cognitive behavior
(mood disturbance, psychosis, anxiety, cognitive impairment or
memory disturbance) (p = 0.046), but reached no statistical
signiﬁcance when corrected for MTLE-HS.
4. Discussion
It is a contemporary phenomenon that diseases from tradition-
ally having been subdivided on the basis of their clinical features
increasingly become deﬁned by their genetic background.
Therefore, current disease classiﬁcations often appear confusing
due to inclusion of both clinical and genetic information. The TLE
usually have been subdivided on the basis of their electroclinical
pattern into neocortical TLE (NTLE) and mesial TLE (MTLE), the
latter further in MTLE with (MTLE-HS) and without hippocampal
sclerosis. The latest proposal for classiﬁcation of epileptic
syndromes by the International League Against Epilepsy (ILAE)
highlights only two distinctive subgroups among the TLE, which
are familial MTLE (FMTLE) and MTLE-HS10; the ﬁrst is deﬁned by
its speciﬁc genetic background, the second on the basis of its
typical clinical presentation. Additionally the classiﬁcation exhi-
bits a third term, ‘‘MTLE deﬁned by speciﬁc etiologies’’, to
encourage further subdivision. As mentioned in the introduction,
subdivision may contribute to challenge pharmacoresistant TLE.
The present study was motivated by ﬁndings from our recent
association study that indicated genetic variation among TLE
patients who have had febrile seizures in childhood (TLE-FS) when
compared with TLE without FS.8 As a result of our ﬁndings we
wanted to test the hypothesis that TLE-FS may display another
subgroup among the TLE. This hypothesis is supported by other
studies that have indicated TLE-FS to constitute a unique entity
distinct from afebrile TLE.2–4 In this respect the question arises
whether TLE-FS present clinical characteristics that allow a
Table 2
Seizure type and ictal symptoms in TLE-FS patients compared with TLE patients without FS.
TLE-FS (n=102) TLE without FS (n=105) p-Value Adjusted for MTLE-HS
p-Value OR 95% CI
Simple partial seizures (SPS) 58 47 0.015 0.038 1.87 1.0–3.4
SPS with autonomic symptoms 44 25 0.003 0.012 2.2 1.2–4.1
SPS with vertiginous symptoms 14 3 0.004 0.006 6.04 1.7–21.9
SPS with motor symptoms 20 12 n.s. n.s.
SPS with somato-sensory symptoms 36 29 n.s. n.s.
SPS with psychic symptoms
(de´ja` vu, jamais vu, ictal fear)
35 23 0.047 n.s.
Complex partial seizures (CPS) 93 97 n.s. n.s.
Generalized tonic–clonic seizures 89 80 0.034 0.038 2.5 1.1–6.4
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previous study in which the phenotype of TLE-FS has been
systematically investigated.
Our study shows that age at afebrile seizure onset is
signiﬁcantly lower in TLE-FS than in the other TLE patients.
Generally, age at disease onset is an important indicator that
facilitates delineation of disorders. Early epilepsy onset is
consistent with particular biological features in the maturing
brain that contribute to its hyperexcitability.11–13 In certain
epileptic conditions, such as probably in TLE-FS, a pathological
reinforcement of these age-speciﬁc factors may predispose to
seizure susceptibility in an early phase of development.
TLE patients with FS also seem to have a more serious condition
than those without FS, as they display higher seizure frequency for
both partial and generalized seizures, and surgery (vagus nerve
stimulator and temporal lobectomy) tended to be more often
conducted. Additionally we observed the higher incidence of ictal
autonomic symptoms, vertiginous symptoms, psychic symptoms,
but we have no good explanation for these observations.
Not surprising, we found that patients with MTLE-HS were
overrepresented in the TLE-FS group. As patientswithMTLE-HS are
known to present a typical clinical picture,14 we conducted logistic
regression analysis (LRA) to adjust for probable confounders
caused by the overrepresentation of MTLE-HS in the TLE-FS group.
LRA conﬁrmed our original ﬁndings and thus strengthened the idea
of TLE-FS to represent a distinctive phenotype.
Certainly, one could ask whether it makes sense to divide TLE-
FS from MTLE-HS as it is supposed that there is a large overlap. On
the other hand it is still one of the most controversial topics
whether febrile seizures are associated with TLE; some studies
conﬁrm such a link,15–17 while others proof the opposite.18,19
At least, TLE-FS patients had the higher frequency of ﬁrst grade
family members with childhood febrile seizures. Febrile Seizures
have principally been regarded as genetically determined, as twin-
and family studies have pointed to an important genetic
component20,21 and epidemiological studies have shown a regional
variation in prevalence.22,23 TLE on the other hand has been
traditionally regarded as an acquired condition. However, lately
several lines of evidence have pointed towards an important role of
genetics in TLE, such as observations of familial monogenic
forms,24,25 the frequent presence of positive familial antecedents
for epileptic events,26 the discovery of autosomal dominant partial
epilepsy with auditory features (ADLTLE)27 and also, if somewhat
controversial, the high association with febrile seizures.28
The most recent ﬁndings have added important information to
the rigid concepts of the TLE ﬁeld and should be taken into
consideration: First, boundaries between simple- and complex FS
are more ﬂuid than earlier predicted and the assumption that only
complex FS may lead to hippocampal injury followed by TLE is no
longer adequate, as even simple FS may cause hippocampal
abnormalities and TLE.29,30 Second, it became more obvious that
only a fraction of patientswith complex FS develop TLE31; and third,patientswith FMTLEmaynot only develop complex, but also simple
FS. The last ﬁnding, even originating only from a few families, ﬁts
nicely into the scope of our study as it demonstrates a coupling
betweena reliable geneticbackground responsible for both complex
and simple febrile seizures and a clear relation to TLE.32,33
Our datawere collected from a relatively small and homogenous
population fromNorway,which is usually considered an advantage.
However, theremay be geographical variations of FS etiology, based
on different genetic and environmental factors around the world.
Additional trials are therefore required to verify our results.
Furthermore, the type of epilepsy that develops after FS depends
on a variety of factors, of which some may be genetic; others may
include characteristics of the FS themselves. Recent studies on
animal models have demonstrated that FS seem to activate cellular
andmolecular mechanisms thatmay have an impact on the clinical
characteristics of the TLE phenotype.34 Furthermore, pathogenic
factors of FS such as inﬂammation ‘‘at a certain time in a certain
place’’ in the brain doubtlessly have an inﬂuence on the phenotype
by affecting anatomy and physiology, regardless genetics.35
Although no genes have been found for the vast majority of FS
and TLE, there is a growing consensus that genetics plays a role in
both conditions. As containing two strong clinical features, the
combination of TLE plus childhood FS may be a predictor for a
genetic basis itself, and it is therefore reasonable to search for
susceptibility genes and also phenotypic characteristics in the
intersection of both conditions. Indeed, we identiﬁed TLE-FS as a
phenotype that can be delineated from other TLE. None of the
characteristics are speciﬁc, but we disclosed a subset of features.
Further research including genetic, clinical and animal studies, are
however needed to settle our results.
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